No definition available.
Mesothelioma, excluding all cancers (controls excluding all cancers)
C3_MESOTHELIOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
451 |
4. Check minimum number of eventsNone |
451 |
5. Include endpointsNone |
451 |
6. Filter based on genotype QC (FinnGen only) |
451 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C45-C49
- Name in latin
- Mesothelioma
Similar endpoints
↥List of similar endpoints to
Mesothelioma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Mesothelioma
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 451 | 117 | 334 |
| Unadjusted period prevalence (%) | 0.12 | 0.04 | 0.15 |
| Median age at first event (years) | 70.24 | 64.97 | 72.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 404
- Matched controls
- 4040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
323.0
299
*
130
Kela drug reimbursment
Malignant tumour
+∞
245.7
210
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
84.3
197.4
216
54
H02AB02
ATC
dexamethasone; systemic
322.0
189.3
179
10
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
135.2
122
*
A03FA01
ATC
metoclopramide; systemic, rectal
19.6
120.9
202
196
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
103.7
95
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
438.7
103.1
99
*
N02AA05
ATC
oxycodone; systemic
13.6
98.4
195
259
Z51.5
ICD-10 Finland
Palliative care
36.7
94.3
122
47
A04AA01
ATC
ondansetron; systemic, rectal
71.3
90.5
102
19
J94.8
ICD-10 Finland
Other specified pleural conditions
58.8
81.5
95
21
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
74.3
69
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
49.2
73.9
89
23
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
24.2
69.0
100
54
JN4BD
NOMESCO Finland
Extensive body CT
14.9
63.1
111
100
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
59.9
56
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
57.7
54
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
51.1
48
*
GAC00
NOMESCO Finland
Biopsy of pleura
121.5
50.1
53
5
TGA30
NOMESCO Finland
Thoracocentesis
52.9
49.8
59
13
A04AA02
ATC
granisetron; systemic, transdermal
271.3
48.1
48
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
27.4
47.1
65
28
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
21.7
44.5
66
36
1BA04
NOMESCO Finland
NA
+∞
42.4
40
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
26.3
42.4
59
26
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.7
39.6
80
91
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
39.2
37
*
L01CA04
ATC
vinorelbine; systemic
+∞
39.2
37
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
402.3
37.7
37
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.2
36.8
111
233
C61
ICD-10 Finland
Malignant neoplasm of prostate
378.2
35.5
35
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
34.9
33
*
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
32.7
31
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
30.6
29
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
89.6
30.2
33
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
52.8
28.9
34
7
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.1
28.7
85
170
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
28.5
241
1251
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
+∞
28.5
27
*
A06AH03
ATC
naloxegol; oral
+∞
27.4
26
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
30.2
27.2
36
13
JN4AD
NOMESCO Finland
Body CT examination
8.9
26.0
57
73
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
144.2
25.9
27
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
25.3
24
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
25.3
24
*
R84
ICPC
Malignant neoplasm bronchus/lung
+∞
24.2
23
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
24.2
23
*
WX600
NOMESCO Finland
Single shot through catheter
57.6
23.3
27
5
WZC30
NOMESCO Finland
Teaching
5.2
22.5
75
170
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.2
22.5
45
49
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
+∞
22.1
21
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.9
22.0
77
184
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
231.9
21.8
22
*
J01MA12
ATC
levofloxacin; systemic
3.5
21.3
119
435
ZX120
NOMESCO Finland
Intravenous
5.7
21.1
64
130
GD1AD
NOMESCO Finland
Thorax CT examination
8.3
20.0
45
60
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
20.0
120
460
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.7
18.1
47
78
B03BA03
ATC
hydroxocobalamin; parenteral
4.7
17.9
64
155
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
7.0
17.9
45
71
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
17.8
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
116
Kela drug reimbursment
Prostate cancer
+∞
17.8
17
*
J01MA14
ATC
moxifloxacin; systemic
4.5
17.8
67
171
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
17.2
126
544
L03AA13
ATC
pegfilgrastim; parenteral
+∞
16.8
16
*
L03AA02
ATC
filgrastim; parenteral
94.0
16.7
18
*
N02AA01
ATC
morphine; systemic, rectal
18.9
16.7
25
14
JN4CD
NOMESCO Finland
Very extensive body CT
13.0
16.1
28
23
GAA31
NOMESCO Finland
Thoracoscopy
62.6
15.9
18
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
16.9
15.4
24
15
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
46.9
15.2
18
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
14.7
14
*
GAC43
NOMESCO Finland
Total decortication of pleura
+∞
14.7
14
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
+∞
14.7
14
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
155.3
14.6
15
*
A79
ICPC
Malignancy NOS
155.3
14.6
15
*
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
13.3
14.1
24
19
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
13.9
49
117
C45
ICD-10 Finland
Mesothelioma
+∞
13.6
13
*
JAL30
NOMESCO Finland
Omentectomy
144.6
13.5
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
13.0
113
529
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
12.8
46
112
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
12.6
12
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
12.6
12
*
R82
ICPC
Pleurisy/pleural effusion
+∞
12.6
12
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
12.6
12
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.4
12.3
37
74
WW500
NOMESCO Finland
Blood transfusion
9.1
12.2
25
29
B01AB10
ATC
tinzaparin; parenteral
5.3
12.1
37
76
TK800
NOMESCO Finland
Hemodialysis
7.5
11.7
27
38
R85
ICPC
Malignant neopl respiratory other
+∞
11.5
11
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
123.3
11.5
12
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.6
11.2
20
18
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
11.0
149
859
Z2446
NOMESCO Finland
Social worker
4.5
10.8
38
91
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
61.6
10.7
12
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
10.7
102
496
GAC30
NOMESCO Finland
Artificial pneumothorax
112.7
10.5
11
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
19.4
10.3
15
8
AA1BD
NOMESCO Finland
Extensive CT of head and brain
10.4
10.1
19
19
J86.9
ICD-10 Finland
Pyothorax without fistula
13.8
9.7
16
12
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.3
9.7
11
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
10.4
9.6
18
18
N03AX16
ATC
pregabalin; oral
2.3
9.4
99
502
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
A04AA03
ATC
tropisetron; systemic
+∞
9.4
9
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
9.4
9
*
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
7.6
9.3
21
29
R18
ICD-10 Finland
Ascites
10.4
9.1
17
17
H02AB06
ATC
prednisolone; systemic
1.9
9.0
193
1305
R06.0
ICD-10 Finland
Dyspnoea
2.1
8.8
121
687
D70.82
ICD-10 Finland
Drug-induced neutropenia
51.1
8.7
10
*
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
51.1
8.7
10
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
8.4
8
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.4
8
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
1638X
ICD-9 Finland
Malignant neoplasm of pleura, Other specified sites of pleura
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
8.4
8
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
8.4
8
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
34.1
8.1
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
34.1
8.1
10
*
Z57.2
ICD-10 Finland
Occupational exposure to dust
13.4
7.9
13
10
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
7.2
7.9
18
26
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
45.8
7.7
9
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
45.8
7.7
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.7
141
891
SPAT1109
SPAT
Analgesia with portable analgesic pump
18.8
7.6
11
6
XX1XW
NOMESCO Finland
Extensive written report from radiologist
7.3
7.6
17
24
R4110
NOMESCO Finland
Physiotherapy
2.0
7.5
108
620
B01AB05
ATC
enoxaparin; parenteral
2.0
7.5
117
695
Y77
ICPC
Malignant neoplasm prostate
81.5
7.4
8
*
SPAT1062
SPAT
Lung clearance therapy
81.5
7.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
7.3
151
988
WW200
NOMESCO Finland
Immunization
6.4
7.3
18
29
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
+∞
7.3
7
*
1580A
ICD-9 Finland
Malignant neoplasm of retroperitoneum and peritoneum, Retroperitoneum
+∞
7.3
7
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
7.3
7
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
7.3
7
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
7.3
7
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
16.1
7.3
11
7
J93.8
ICD-10 Finland
Other pneumothorax
30.6
7.2
9
*
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
20.4
7.2
10
5
N02AX02
ATC
tramadol; systemic, rectal
1.8
7.1
170
1166
WX402
NOMESCO Finland
General anaesthesia
2.5
7.0
54
232
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
7.0
55
240
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
40.7
6.8
8
*
6101
FHL
Exploratory laparotomy, includes possible biopases
17.0
6.8
10
6
ZX112
NOMESCO Finland
Subcutaneous
17.0
6.8
10
6
JAH01
NOMESCO Finland
Laparoscopy
6.1
6.7
17
29
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
6.6
54
241
N06DX01
ATC
memantine; oral
0.1
6.5
*
236
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
70.9
6.4
7
*
GAC46
NOMESCO Finland
Partial decortication of pleura
70.9
6.4
7
*
WF002
NOMESCO Finland
Radical radiotherapy
70.9
6.4
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
70.9
6.4
7
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
6.3
72
1182
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
+∞
6.3
6
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
6.3
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
GAC96
NOMESCO Finland
Other operation on pleura
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
6.3
6
*
SPAT1088
SPAT
Blood transfusion
27.1
6.2
8
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.8
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768806) Pleura Pathology biopsy report
146
31
69.16
259.43
2.3
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
143
45
46.07
230.07
2.0
1.3
e6/l
1669.8
2265.6
0.42
118
32
(3028308) Erythrocytes [#/volume] in Pleural fluid
139
42
47.39
226.02
2.0
1.4
e6/l
41882.1
57698.5
0.14
102
25
(3012441) Differential panel - Pleural fluid
134
38
49.75
221.44
1.9
1.3
—
—
—
0
0
(4035726)
154
96
23.84
190.84
1.7
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
99
38
33.10
147.54
2.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
107
73
18.91
124.54
2.1
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
127
132
13.00
114.91
2.2
3.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
136
184
10.15
100.81
2.3
1.3
ug/l
2.2
4.7
0.94
107
140
(3035880) pH of Pleural fluid
61
20
35.11
94.52
1.6
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
172
496
4.99
57.08
2.6
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
166
485
4.83
53.80
5.4
2.7
mmol/l
0.8
0.8
5.48
158
447
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
70
91
8.92
52.05
1.5
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
144
395
4.89
50.11
3.1
2.7
u/l
208.7
243.4
7.38
144
367
(40768804) Tissue Pathology biopsy report
191
891
2.98
27.51
2.8
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
209
1035
2.90
26.80
6.7
5.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
204
1030
2.79
24.75
6.1
4.0
—
—
—
0
0
(4281824)
19
13
15.21
21.17
1.4
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
265
1609
2.57
21.05
11.9
3.9
umol/l
9.8
12.9
3.10
260
1499
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
117
4.68
20.25
2.8
2.6
u/ml
0.3
0.4
0.75
28
64
(3013650) Neutrophils [#/volume] in Blood by Automated count
277
1747
2.52
19.83
16.5
5.8
e9/l
5.2
4.5
1.27
244
1509
(3033658) Prothrombin time (PT) actual/Normal
158
778
2.59
19.20
8.3
3.6
%
84.7
80.4
1.59
151
757
(3002030) Lymphocytes/100 leukocytes in Blood
241
1459
2.40
18.43
7.4
5.4
%
20.5
25.5
9.59
236
1337
(3019069) Monocytes/100 leukocytes in Blood
238
1437
2.39
18.25
7.5
5.4
%
9.6
8.9
2.40
232
1326
(3042631) Mycobacterium sp identified in Specimen
29
46
6.67
17.77
2.4
2.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
20
20
10.42
17.71
2.0
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
224
3130
0.44
16.67
5.6
6.9
mmol/mol
41.0
41.3
0.22
196
2861
(3001604) Monocytes [#/volume] in Blood
246
1559
2.27
16.19
6.9
5.0
e9/l
0.7
0.6
5.58
209
1331
(3000494) Fungus identified in Specimen by Culture
90
360
2.87
16.19
1.5
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
246
1565
2.26
15.96
6.9
5.0
e9/l
0.0
0.0
0.04
211
1345
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
71
5.10
15.69
1.2
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
247
1584
2.24
15.59
7.0
5.1
e9/l
1.6
1.8
3.88
213
1376
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
242
1549
2.21
15.23
8.0
5.2
mmol/l
1.2
1.2
0.20
230
1369
(40758558) Short blood count panel - Blood
138
700
2.40
15.20
12.4
4.4
—
—
—
0
0
(3002256) Pathology report gross observation
66
229
3.20
15.18
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
240
1541
2.19
14.86
6.0
11.5
inr
1.1
1.4
9.90
40
418
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
257
1702
2.19
14.63
9.5
5.7
mmol/l
1.2
1.2
0.18
228
1447
(3024561) Albumin [Mass/volume] in Serum or Plasma
229
1450
2.18
14.62
7.7
3.7
g/l
30.5
35.0
17.84
222
1325
(3013115) Eosinophils [#/volume] in Blood
246
1614
2.15
14.19
7.4
5.2
e9/l
0.2
0.2
0.63
214
1398
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
250
3284
0.46
13.94
3.8
5.6
mmol/l
2.5
2.5
0.17
207
2962
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
141
748
2.29
13.82
3.3
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
242
3206
0.47
13.57
3.6
4.9
mmol/l
4.3
4.3
0.11
203
2908
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
238
3170
0.47
13.51
3.7
4.9
mmol/l
1.4
1.4
0.13
201
2854
(3044640) Blood type and Crossmatch panel - Blood
168
965
2.18
13.49
3.6
2.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
11
12.14
12.68
1.6
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
38
6.04
12.38
1.1
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
166
982
2.09
12.09
5.0
3.3
ph
7.4
7.4
0.87
26
157
(3015377) Calcium [Moles/volume] in Serum or Plasma
175
1063
2.06
11.81
6.3
2.1
mmol/l
2.3
2.3
0.14
158
852
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
253
2.73
11.07
4.4
3.9
mmol/l
2.9
1.9
1.48
57
190
(3009343) pH of Capillary blood
65
268
2.67
10.85
4.4
3.9
ph
7.4
7.4
—
6
29
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
120
650
2.15
10.83
5.9
2.1
mmol/l
2.5
2.4
10.31
108
539
(3022313) Gas panel - Capillary blood
53
205
2.80
9.98
4.5
4.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
238
3062
0.53
9.91
3.3
4.4
mmol/l
1.2
1.3
0.70
195
2725
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
262
3264
0.53
9.59
4.7
5.1
mmol/l
6.2
6.1
0.20
228
2912
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
50
4.57
9.18
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
187
2.69
8.38
11.9
9.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
27
5.71
8.07
1.5
1.9
u/l
2.6
13146.5
—
5
7
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
144
930
1.81
7.42
4.1
2.5
u/l
34.0
37.3
0.37
135
883
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
34
4.84
7.22
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
69
1222
0.49
7.15
2.8
3.3
mg/l
26.4
198.6
1.51
44
812
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
71
3.51
7.07
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
72
3.46
6.93
3.5
3.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
219
2.39
6.87
1.7
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
108
654
1.86
6.78
1.8
1.6
mg/l
1.8
1.5
0.62
88
514
(3026782) Osmolality of Urine
113
695
1.84
6.75
2.5
2.5
mosm/kgh2o
543.5
568.5
0.63
100
568
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
200
1450
1.68
6.67
5.2
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
77
1292
0.51
6.67
3.8
4.0
mg/mmol
6.5
9.8
0.65
45
849
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
242
2975
0.60
6.62
5.2
4.2
mu/l
2.1
2.0
0.36
218
2643
(3009508) Creatinine [Moles/volume] in Urine
72
1229
0.51
6.56
2.8
3.2
mmol/l
8.9
7.7
1.29
55
1017
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
75
3.32
6.52
1.3
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
80
446
1.96
6.43
9.0
6.0
mmol/l
1.8
1.4
0.62
70
339
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
42
4.17
6.41
1.5
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
103
626
1.84
6.36
2.0
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
136
910
1.71
6.00
2.6
3.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
11
20
5.61
5.83
1.4
1.5
pmol/l
100.9
59.5
1.70
11
20
(3000991) Gas panel - Venous blood
60
314
2.05
5.73
11.7
7.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
142
972
1.67
5.72
2.6
3.0
e6/l
0.9
0.5
0.81
112
722
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
7
13.08
5.60
1.7
1.3
nmol/l
2.3
5.7
—
9
7
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
221
2.20
5.47
1.8
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
148
1041
1.63
5.29
3.7
2.1
u/l
53.6
57.3
0.63
139
960
(3052851) Hemolysis interference index of Serum or Plasma
27
103
2.72
5.25
4.9
3.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
27
4.54
5.06
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
41
3.75
4.96
1.3
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
78
468
1.81
4.96
5.5
5.5
mmol/l
1.0
1.0
0.03
73
423
(3033799) Differential panel - Peritoneal fluid
8
7
11.60
4.80
1.3
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
116
1624
0.62
4.79
1.8
2.1
pmol/l
95.5
91.6
0.38
69
862
(3002582) Erythrocytes [#/volume] in Urine
147
1063
1.57
4.57
2.7
3.1
e6/l
49.1
142.7
0.79
118
814
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
171
1282
1.54
4.51
2.6
3.1
—
—
—
0
0
(3000492) Spirometry study
45
233
2.03
4.44
1.4
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
9
9.02
4.29
1.1
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
8
9
9.02
4.29
2.4
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
74
457
1.74
4.25
11.0
5.8
mmol/l
103.7
104.4
0.71
74
445
(3037522) Nuclear Ab [Titer] in Serum
63
371
1.81
4.25
1.4
1.3
titre
420.0
523.9
0.29
12
93
(3013826) Glucose [Moles/volume] in Serum or Plasma
250
2057
1.48
4.09
8.1
4.4
mmol/l
6.9
7.0
0.34
241
1928
(40767503) Oxygen content in Capillary blood by calculation
20
75
2.74
4.04
2.3
2.2
%
15.3
16.4
—
10
39
(3010813) Leukocytes [#/volume] in Blood
320
3563
0.65
4.00
46.7
21.2
e9/l
8.3
6.9
3.17
305
3422
(3000963) Hemoglobin [Mass/volume] in Blood
320
3563
0.65
4.00
46.8
21.3
g/l
124.1
135.5
25.52
310
3474
(3026361) Erythrocytes [#/volume] in Blood
320
3562
0.65
3.98
46.6
21.2
e12/l
4.3
4.5
8.00
304
3417
(3035941) MCH [Entitic mass]
320
3562
0.65
3.98
46.4
21.1
pg
29.5
30.6
16.45
310
3477
(3024731) MCV [Entitic volume]
320
3561
0.65
3.96
46.5
21.1
fl
90.2
91.8
6.86
310
3476
(3007461) Platelets [#/volume] in Blood
320
3561
0.65
3.96
46.6
21.2
e9/l
294.6
233.3
24.59
304
3439
(1761868) Lipid panel - Serum or Plasma
58
929
0.57
3.95
2.9
3.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
179
1392
1.47
3.82
13.4
8.5
e9/l
0.0
0.0
0.45
134
1125
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
1596
0.65
3.81
3.5
4.0
%
22.7
24.7
0.79
61
808
(3044007) Cell count panel - Peritoneal fluid
7
8
8.86
3.78
1.4
2.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
25
4.07
3.71
1.1
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
25
4.07
3.71
6.8
2.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
292
2504
1.47
3.69
14.9
5.2
u/l
91.5
77.6
3.23
282
2280
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
156
1975
0.68
3.69
4.3
4.2
ug/l
2.6
2.1
0.90
126
1759
(3051651) Icteric interference index of Serum or Plasma
9
16
5.72
3.67
7.1
2.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
194
2348
0.70
3.52
4.4
3.3
pmol/l
14.9
15.0
0.11
176
2076
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
41
3.24
3.52
2.1
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
436
1.66
3.40
1.9
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
42
3.16
3.39
1.5
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
315
3480
0.69
3.23
35.7
18.0
mmol/l
4.0
4.0
0.08
304
3373
(3021960) Folate [Moles/volume] in Serum or Plasma
68
998
0.62
3.20
1.5
1.6
nmol/l
22.5
20.1
0.62
63
831
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
560
1.57
3.18
2.3
2.9
e6/l
1.9
1.8
0.01
45
318
(3003181) Sodium [Moles/volume] in Urine
16
61
2.68
3.17
1.6
1.3
mmol/l
87.4
62.8
—
9
50
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
340
0.39
3.16
1.9
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
315
3472
0.69
3.08
35.6
17.9
mmol/l
138.3
139.8
11.67
305
3365
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
311
3434
0.70
3.05
18.3
9.3
u/l
24.4
25.2
0.42
301
3261
(3018095) Leukocytes [#/volume] in Urine
154
1208
1.42
2.99
3.2
3.5
e6/l
94.4
97.4
0.02
121
869
(40768800) Prostate Pathology biopsy report
10
30
3.39
2.92
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
439
1.59
2.86
1.8
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
303
3346
0.71
2.80
31.0
14.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
6
8.41
2.75
1.6
1.2
nmol/l
74.8
75.8
—
5
6
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
98
2.20
2.75
1.5
1.6
iu/ml
0.0
0.2
—
7
22
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
245
1.74
2.67
2.0
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
49
746
0.62
2.66
4.1
4.3
kg/l
1.0
1.0
—
6
118
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
61
2.51
2.64
1.5
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
68
0.00
2.62
0.0
1.2
—
—
—
0
0
(4062490)
9
25
3.65
2.58
1.6
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
61
877
0.65
2.57
1.7
1.8
pmol/l
497.7
8039909.6
0.50
52
709
(3022806) Fractional oxyhemoglobin in Capillary blood
12
44
2.77
2.56
1.8
1.6
%
88.0
89.9
0.79
12
44
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
50
2.65
2.55
1.5
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
16
4.43
2.48
1.7
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
16
4.43
2.48
1.7
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.86
2.47
1.8
1.3
—
—
—
0
0
(3010421) pH of Blood
19
90
2.16
2.42
4.8
4.1
ph
7.4
7.4
0.63
19
71
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
78
2.23
2.34
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
78
2.23
2.34
1.6
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
28
3.26
2.32
3.0
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
97
732
1.41
2.29
2.4
2.4
e6/l
4.5
4.3
0.08
88
629
(3021901) Oxygen saturation in Capillary blood
17
79
2.20
2.27
2.6
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
99
1271
0.72
2.25
2.1
2.1
nmol/l
74.6
77.1
0.37
84
1075
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
67
2.28
2.20
1.5
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
98
747
1.40
2.18
5.1
3.9
ng/l
96.9
319.0
1.95
84
639
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
102
2.01
2.13
1.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
131
1599
0.75
2.12
3.8
3.8
estimate
0.0
0.0
0.00
32
264
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
49
2.49
2.12
4.0
2.1
e9/l
4.1
4.6
0.41
12
49
(3019225) pH of Specimen
52
352
1.54
2.12
6.3
3.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
68
488
1.46
2.10
2.2
2.5
%
17.1
23.2
3.40
61
414
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
31
185
1.73
2.07
3.9
4.0
mmol/l
25.1
24.2
0.56
31
167
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
50
2.44
2.04
4.2
2.5
%
58.8
59.3
0.04
12
50
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
163
1.77
2.03
2.4
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
100
778
1.37
1.96
1.3
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
11
4.58
1.94
1.6
5.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
131
1581
0.76
1.91
3.8
3.8
estimate
0.0
0.0
0.00
32
271
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
34
2.68
1.87
1.1
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
131
1576
0.76
1.86
5.0
5.1
estimate
0.0
0.0
0.00
33
267
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
79
598
1.39
1.83
2.2
2.7
e6/l
1.7
1.0
0.67
42
355
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
12
4.20
1.83
1.6
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
12
4.20
1.83
1.6
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
87
1.99
1.82
2.1
2.0
g/l
127.1
133.1
0.23
11
65
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
30
2.70
1.73
1.1
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
266
0.51
1.72
6.6
2.1
ml/min/173m2
67.7
59.2
—
7
105
(3007853) Bacteria identified in Skin by Aerobe culture
55
395
1.45
1.71
1.7
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
26
2.72
1.58
2.9
2.9
—
—
—
0
0
(44790049)
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
(44806118)
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
(44790048)
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
(44790047)
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
238
2625
0.80
1.53
40.7
19.4
g/l
326.3
332.5
15.11
232
2599
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
15
3.36
1.52
1.6
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
15
3.36
1.52
1.6
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
51
2.19
1.51
1.6
1.2
—
—
—
0
0
(3020891) Body temperature
8
167
0.47
1.50
2.4
4.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
228
0.51
1.50
2.1
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
101
1223
0.78
1.45
4.1
4.0
—
—
—
0
0
(4010399)
35
238
1.51
1.44
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
280
3025
0.80
1.44
29.9
13.4
ml/min/173m2
76.7
72.8
2.59
253
2440
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
138
0.43
1.42
1.3
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
29
2.44
1.39
2.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
30
199
1.54
1.39
3.1
3.0
e9/l
5.3
3.9
1.13
21
134
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
151
1.62
1.38
2.3
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
17
2.96
1.36
2.2
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
61
781
0.75
1.32
3.4
3.8
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
24
2.52
1.31
3.3
4.1
mmol/l
8.0
7.5
—
6
12
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
34
2.38
1.29
1.1
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
74
587
1.31
1.29
2.2
2.4
umol/l
8.3
12.7
10.87
69
531
(3019832) Treponema pallidum Ab [Presence] in Serum
5
118
0.42
1.26
1.2
1.4
—
—
—
0
0
(3015736) pH of Urine
107
1262
0.80
1.21
3.5
3.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
183
0.54
1.14
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
30
2.35
1.12
2.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
30
2.35
1.12
2.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
30
2.35
1.12
2.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
30
2.35
1.12
2.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
30
2.35
1.12
2.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
220
2403
0.84
1.12
3.9
4.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
20
300
0.65
1.08
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
332
0.68
1.03
2.3
3.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
276
1.37
0.99
3.0
4.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
29
0.00
0.98
0.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
54
1.87
0.97
1.7
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
35
260
1.38
0.96
4.7
3.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
32
0.00
0.95
0.0
3.1
—
19.7
—
0
25
(3018572) Chloride [Moles/volume] in Blood
14
85
1.67
0.95
5.4
5.8
mmol/l
103.2
105.5
0.60
14
80
(3039000) Anion gap in Blood
14
85
1.67
0.95
5.4
5.8
mmol/l
10.1
11.5
0.89
14
80
(3045414) Leukocytes [Presence] in Urine
6
119
0.50
0.95
1.7
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(4306422)
6
29
2.08
0.89
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
501
0.76
0.89
8.5
7.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
117
1324
0.84
0.85
2.7
2.7
ug/l
427.1
158.5
2.49
110
1197
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
137
0.58
0.84
1.1
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
145
1299
1.17
0.82
3.2
3.1
ng/l
1311.5
1831.1
1.35
133
1121
(3029937) Albumin [Presence] in Urine by Test strip
76
888
0.83
0.78
4.3
3.9
estimate
0.0
0.0
0.00
31
255
(3002385) Erythrocyte distribution width [Ratio]
242
2578
0.87
0.78
40.3
17.1
%
14.6
13.8
11.04
234
2507
(3021447) Carbon dioxide [Partial pressure] in Venous blood
49
398
1.26
0.76
3.9
3.5
kpa
6.1
5.8
0.71
49
387
(3017446) Testosterone [Moles/volume] in Serum or Plasma
16
231
0.68
0.75
1.9
2.3
nmol/l
10.2
15.0
1.52
16
200
(3007164) IgA [Mass/volume] in Serum or Plasma
40
498
0.78
0.74
1.4
1.2
g/l
2.1
2.9
0.95
21
288
(3004588) Protein electrophoresis panel - Serum or Plasma
19
264
0.71
0.73
1.1
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
60
1.68
0.72
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
20
143
1.42
0.71
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
72
837
0.83
0.71
1.7
1.8
nmol/l
1098.3
1136.9
0.13
46
630
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
34
267
1.30
0.69
2.0
1.9
g/l
0.2
0.2
0.65
34
236
(3000330) Specific gravity of Urine by Test strip
14
203
0.68
0.68
3.9
3.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
136
1.41
0.68
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
62
1.63
0.65
1.3
2.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
26
201
1.31
0.60
3.5
3.9
%
0.4
0.5
0.11
12
37
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
1.0
—
0
11
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
21
0.00
0.60
0.0
1.1
—
13.3
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
22
0.00
0.59
0.0
2.2
—
4.5
—
0
16
(4027681)
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
231
2440
0.89
0.58
4.2
4.1
mm/h
26.0
13.0
8.50
220
2195
(4094501)
5
87
0.57
0.56
1.4
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
123
0.64
0.55
1.0
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
479
0.82
0.55
4.3
5.1
%
34.6
32.3
0.56
28
319
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
39
1.55
0.53
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
72
813
0.86
0.52
3.9
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
313
3237
0.89
0.51
37.3
14.5
mg/l
49.2
26.8
15.11
294
2543
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
201
0.74
0.50
2.4
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
27
217
1.26
0.49
3.4
3.9
%
0.1
0.1
0.32
14
44
(3026493) Urate [Moles/volume] in Serum or Plasma
84
934
0.88
0.49
2.6
2.7
umol/l
4145.4
9738.3
0.69
69
792
(3017181) Myelocytes/100 leukocytes in Blood
28
228
1.24
0.46
3.3
3.8
%
0.6
0.7
0.14
14
51
(3040151) Glucose [Moles/volume] in Capillary blood
7
51
1.38
0.44
1.9
6.2
mmol/l
6.6
7.4
—
7
40
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
51
1.38
0.44
1.1
5.4
iu/ml
—
191.0
—
0
5
(3043409) Potassium [Moles/volume] in Arterial blood
9
129
0.69
0.44
1.6
3.7
mmol/l
3.9
3.9
—
9
120
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
99
1081
0.89
0.44
3.0
2.9
ug/l
0.8
0.8
0.23
75
771
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
56
1.44
0.42
1.3
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
195
0.76
0.42
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
304
0.81
0.42
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
126.5
—
0
16
(3006462) Nitrate [Presence] in Urine
0
16
0.00
0.41
0.0
4.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.1
—
35.8
—
0
11
(4211845)
0
17
0.00
0.40
0.0
4.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
34
1.48
0.40
1.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.2
—
29.6
—
0
13
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
67
1.35
0.38
3.4
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
98
1.34
0.38
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
98
1.34
0.38
1.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
70
1.29
0.37
3.4
2.6
mmol/l
4.4
4.1
—
9
70
(3035285) Chloride [Moles/volume] in Venous blood
9
70
1.29
0.37
3.4
2.6
mmol/l
104.9
104.4
—
9
70
(42529406) Shigella sp [Presence] in Stool by Culture
13
100
1.31
0.34
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
64
1.25
0.27
1.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
206
1.17
0.27
3.4
4.0
%
0.1
0.0
0.28
12
39
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
160
0.81
0.26
1.1
1.3
g/l
3.7
3.9
—
8
109
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
160
0.81
0.26
1.1
1.3
g/l
8.6
7.6
—
8
113
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
160
0.81
0.26
1.1
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
77
1.31
0.26
1.1
1.2
—
3.3
—
0
12
(3021788) Differential panel - Synovial fluid
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
54
590
0.90
0.26
12.2
31.4
inr
1.2
1.5
—
5
80
(3049717) Cytology report of Urine Cyto stain
17
142
1.20
0.25
2.1
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
332
1.12
0.24
1.5
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
125
1.21
0.22
2.0
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.2
nmol/l
0.6
0.6
—
5
36
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
7.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
7.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
10
0.00
0.21
0.0
1.1
—
200.1
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
1761.8
—
0
12
(3048879) Bone marrow aspiration report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
8.5
—
0
12
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
13
0.00
0.21
0.0
7.2
—
24.9
—
0
13
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.1
—
236.7
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
183
1.15
0.20
1.3
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
492
1.09
0.19
1.3
1.3
iu/ml
33.2
41.3
0.26
12
138
(40760892) CBC W Ordered Manual Differential panel - Blood
59
628
0.93
0.17
4.8
4.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
63
1.11
0.17
1.3
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
167
1.14
0.17
5.2
4.2
%
0.9
0.9
0.08
19
161
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
41
379
1.09
0.17
2.0
3.1
ng/l
166.8
242.0
1.01
36
353
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
457
1.08
0.17
1.2
1.3
u/ml
36.6
13.0
0.46
11
157
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
68
1.18
0.16
1.1
1.1
—
13.7
—
0
6
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
69
1.16
0.16
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
83
1.21
0.15
12.3
3.2
mg/l
1.7
1.7
—
10
71
(3026008) Bacteria identified in Urine by Culture
96
998
0.95
0.14
3.8
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
106
0.85
0.13
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
93
965
0.95
0.13
2.0
2.1
mg/l
3.6
3.0
1.30
85
813
(3037467) Urinalysis macro (dipstick) panel - Urine
234
2299
1.04
0.13
4.5
4.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
19
171
1.12
0.12
4.7
4.1
%
2.0
1.7
0.85
19
165
(40768443) Skin Pathology biopsy report
14
123
1.14
0.12
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
425
0.94
0.12
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
147
1506
0.96
0.11
2.5
2.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
31
330
0.93
0.10
5.0
2.9
kpa
4.6
4.5
0.17
31
318
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
114
1169
0.97
0.09
2.6
2.2
u/l
331.4
291.6
0.20
109
1075
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
66
1.06
0.08
2.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
67
1.05
0.08
1.3
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
68
1.03
0.08
2.4
2.4
%
58.4
63.1
—
7
68
(3024928) Oxygen saturation in Venous blood
9
84
1.07
0.07
2.1
2.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
102
0.88
0.06
1.1
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
109
1.10
0.06
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
155
1529
1.02
0.05
4.9
4.1
ng/l
38.7
75.0
0.87
133
1177
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
187
1888
0.98
0.04
4.9
3.0
u/l
62.2
51.4
0.76
171
1722
(3009542) Hematocrit [Volume Fraction] of Blood
278
2763
1.02
0.04
34.2
16.0
%
37.8
38.9
1.33
180
1655
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
369
1.03
0.03
5.3
3.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
92
1.09
0.03
1.3
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
243
1.03
0.01
1.4
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
115
0.96
0.00
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
117
1.03
0.00
4.1
4.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
264
0.98
0.00
1.4
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
201
0.99
0.00
3.2
2.6
%
1.3
1.1
0.98
20
201
(3023520) Reticulocytes [#/volume] in Blood
38
381
1.00
0.00
2.2
2.2
e9/l
64.5
67.2
0.18
25
301
(3013512) EKG study
112
1125
0.99
0.00
4.9
4.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
51
506
1.01
0.00
2.0
2.1
%
1.7
1.7
0.01
45
445
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
67.2
—
0
5
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.6
—
0
5
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
5.7
—
6.4
—
0
7
(3037121) Protein [Mass/volume] in Urine
13
130
1.00
0.00
1.7
2.7
g/l
0.2
0.3
—
6
37
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
17.1
—
0
7
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
95
0.95
0.00
1.3
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
5
49
1.02
0.00
1.2
2.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
8.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.9
—
841.4
—
0
9
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.6
—
0.7
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
92.0
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
7.9
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
7
0.00
0.00
0.0
47.9
—
7.6
—
0
7
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
86.8
—
0
5
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
18.0
—
1581.6
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MESOTHELIOMA_EXALLC – Mesothelioma, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).